Target intelligence / Profile preview

Colonic mucosal surface and stool

Molecular classification
Other, Physiological site, Biological matrix
01

Overview

The colonic mucosal surface and stool represent the physiological environment and luminal contents of the large intestine, serving as a critical interface between the host and the external environment. The colonic mucosa is composed of an epithelial layer, a protective mucus barrier, and the underlying lamina propria, which together facilitate water and electrolyte absorption while preventing the translocation of pathogens (Source: NIH/NCBI). Stool, or fecal matter, serves as a diagnostic matrix containing undigested material, metabolic byproducts, and the gut microbiota, which plays a vital role in metabolic and immune homeostasis (Source: PubMed). Although not a single molecular target, this site is the therapeutic destination for locally acting agents such as aminosalicylates for ulcerative colitis and non-absorbable antibiotics for enteric infections (Source: StatPearls). Monitoring this environment through biomarkers like fecal calprotectin or microbial sequencing provides insights into disease states such as inflammatory bowel disease and dysbiosis (Source: PubMed).

Other names
Colonic mucosaIntestinal lumenFecal matterLarge intestinal surfaceGut-lumen interface
02

Mechanism of action

Drugs acting at this site typically exert local anti-inflammatory effects on the epithelium, modulate the luminal microbiome, or alter the osmotic gradient and motility within the colon without requiring systemic absorption.

03

Biological functions

Barrier functionWater and electrolyte absorptionMicrobiome habitatWaste eliminationImmune surveillance
04

Disease associations

Inflammatory bowel diseaseColorectal cancerEnteric infectionDysbiosisIrritable bowel syndrome
05

Safety considerations

Systemic absorption through compromised mucosaDisruption of commensal flora (dysbiosis)Risk of Clostridioides difficile overgrowthLocal mucosal irritation
06

Interacting drugs

Mesalamine

5 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal immunochemical test (FIT)Fecal occult bloodMicrobiome diversity indexM2-pyruvate kinase

Beyond the preview

Go deeper on Colonic mucosal surface and stool.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic mucosal surface and stool.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call